CDH1 and neoplasm: Our findings showed that dramatic downregulation of exosomal PD-L1, E-cadherin, ULBP1, ULBP3, MICA, MICB, Siglec7 and significant upregulation of exosomal PD-1 and IFN-gamma were associated with tumor regression.